Skip to main content
Clinical Trials/CTRI/2019/05/019477
CTRI/2019/05/019477
Completed
Phase 2

Evaluation of clinical and antimicrobial efficacy of chitosan nanoparticle gel (1%) as a local drug delivery in chronic periodontitis patients- a randomised controlled split mouth trial.

Dayananda Sagar College of Dental Sciences0 sites26 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dayananda Sagar College of Dental Sciences
Enrollment
26
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 12, 2021
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dayananda Sagar College of Dental Sciences

Eligibility Criteria

Inclusion Criteria

  • Probing pocket depth 5mm to 8mm.
  • Clinical attachment level of 3mm.
  • Vertical bone loss greater than 3mm on digital radiographs

Exclusion Criteria

  • Patients with systemic diseases.
  • Patients who have undergone periodontal treatment in last 6 months.
  • Pregnant and lactating mothers.
  • Smokers, alcoholics, drug abusers.

Outcomes

Primary Outcomes

Not specified

Similar Trials